It's How Medicine Should Be®


French German Italian Portuguese Russian

Clinical Trials

Acamprosate Fragile X Syndrome (Ages 5-22)

Study of acamprosate in youth with fragile X syndrome versus placebo

Down Syndrome Symptom Treatment Study

A multicenter, randomized, double-blind, placebo-controlled, multiple dose study to investigate safety and tolerability of RO5186582 in individuals with Down syndrome (Study BP25543).

Efficacy, Safety and Tolerability of RO5186582 in Adults and Adolescents with Down Syndrome

A multi-center, randomized, double-blind, placebo-controlled study of the efficacy, safety and tolerability of RO5186582 in adults and adolescents with Down syndrome

Fragile X Study: Long-Term Safety and Efficacy of Investigational Drug (Adolescent)

An open-label study to evaluate the long-term safety and efficacy of an investigational drug in adolescents with fragile X syndrome

Fragile X Study: Premutation Carriers

Neurological phenotype in FMR1 premutation carriers

Fragile X Syndrome Treatment With NNZ-2566 Compared to Placebo

Study of drug NNZ-2566 in fragile X syndrome compared to placebo